首页> 外文期刊>Biomaterials >Genipin-crosslinked catechol-chitosan mucoadhesive hydrogels for buccal drug delivery
【24h】

Genipin-crosslinked catechol-chitosan mucoadhesive hydrogels for buccal drug delivery

机译:Genipin-Crosslinded儿茶酚 - 壳聚糖粘膜粘接性水凝块用于口腔药物递送

获取原文
获取原文并翻译 | 示例
           

摘要

Drug administration via buccal mucosa is an attractive drug delivery strategy due to good patient compliance, prolonged localized drug effect, and avoidance of gastrointestinal drug metabolism and first-pass elimination. Buccal drug delivery systems need to maintain an intimate contact with the mucosa lining in the wet conditions of the oral cavity for long enough to allow drug release and absorption. For decades, mucoadhesive polymers such as chitosan (CS) and its derivatives have been explored to achieve this. In this study, inspired by the excellent wet adhesion of marine mussel adhesive protein, we developed a buccal drug delivery system using a novel catechol-functionalized CS (Cat-CS) hydrogel. We covalently bonded catechol functional groups to the backbone of CS, and crosslinked the polymer with a non-toxic crosslinker genipin (GP). We achieved two degrees of catechol conjugation (9% and 19%), forming Cat9-CS/GP and Cat19-CS/GP hydrogels, respectively. We confirmed covalent bond formation during the catechol functionalization and GP crosslinking during the gel formation. The gelation time and the mechanical properties of Cat-CS hydrogels are similar to those of CS only hydrogels. Catechol groups significantly enhanced mucoadhesion in vitro (7 out of the 10 Cat19-CS hydrogels were still in contact with porcine mucosal membrane after 6 h, whereas all of the CS hydrogels lost contact after 1.5 h). The new hydrogel systems sustained the release of lidocaine for about 3 h. In-vivo, we compared buccal patches made of Cat19-CS/GP and CS/GP adhered to rabbit buccal mucosa. We were able to detect lidocaine in the rabbit's serum at concentration about 1 ng/ml only from the Cat19-CS patch, most likely due to the intimate contact provided by mucoadhesive Cat19-CS/GP systems. No inflammation was observed on the buccal tissue in contact with any of the patches tested. These results show that the proposed catechol-modified CS hydrogel is a promising mucoadhesive and biocompatible hydrogel system for buccal drug delivery. (C) 2014 Elsevier Ltd. All rights reserved.
机译:通过口腔粘膜药物给药是一种有吸引力的药物递送策略,由于良好的患者依从性,延长的局部药物作用,避免胃肠药物代谢和首先消除。口腔药物递送系统需要与口腔的湿条件中的粘膜衬里保持紧密接触,足以允许药物释放和吸收。几十年来,已经探讨了壳聚糖(CS)和其衍生物等粘膜粘附聚合物以实现这一目标。在这项研究中,灵感来自海洋贻贝粘合剂蛋白质的优异湿粘附,我们使用新型儿茶酚官能化Cs(CAT-CS)水凝胶开发了一种颊剂药物递送系统。我们将儿茶酚官能团与Cs的骨架共价键合,并用无毒交联剂Genipin(GP)交联聚合物。我们达到了两度的儿茶酚共轭(9%和19%),分别形成CAT9-CS / GP和CAT19-CS / GP水凝胶。在凝胶形成期间,我们确认了在儿茶酚官能化和GP交联期间的共价键形成。 CAT-CS水凝胶的凝胶化时间和机械性能类似于CS的水凝胶。儿茶醇组在体外显着增强粘膜粘附(10只CAT19-CS水凝胶中的7个仍然与6小时后仍然接触猪粘膜膜,而所有CS水凝胶在1.5小时后丧失接触。新的水凝胶系统持续释放利多卡因约3小时。在体内,我们将用CAT19-CS / GP和CS / GP制成的颊斑并粘附在兔颊粘膜上。我们能够在Cat19-CS贴片中浓度检测兔血清中的利多卡因,很可能是由于Mucoadgesive CAT19-CS / GP系统提供的紧密接触。在与测试的任何贴剂接触的口腔组织上没有观察到炎症。这些结果表明,该提出的儿茶酚改性的CS水凝胶是一种有前途的粘膜粘附和生物相容性水凝胶系统,用于颊药物递送。 (c)2014年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号